Childhood Favorable Prognosis Hodgkin Lymphoma Active Not Recruiting Phase 3 Trials for Filgrastim (DB00099)

IndicationStatusPhase
DBCOND0034727 (Childhood Favorable Prognosis Hodgkin Lymphoma)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00302003Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's LymphomaTreatment